Faculty profile

Sophie Lauzier

ResearcherUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Sophie Lauzier

Researcher

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
16 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

129

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adjuvant Endocrine Therapy Breast Cancer Cancer Du Sein Hormonothérapie Adjuvante Pilot Study Survivorship Cancer Digital Platform

Latest papers

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.
Current oncology (Toronto, Ont.) · 2026
Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis.
BJPsych open · 2026
Coronary Heart Disease Attributable to Psychosocial Stressors at Work.
JACC. Advances · 2025

All 47 publications

Latest funding

PRIME-OncoTransition for Breast Cancer : A smooth hospital-community transition for people aged 65+ undergoing Post-tReatment preventIve MEdication.
CIHR · 2025 · Nominated PI
$300,000
Favoriser l'engagement des femmes ayant eu un cancer du sein dans les décisions concernant l'hormonothérapie adjuvante prolongée
CIHR · 2023 · Nominated PI
$497,251
Révolutionner la gestion de la douleur totale en soins palliatifs oncologiques : Une approche intégrative pharmacogénomique-spirituelle
SSHRC · 2023 · Co-investigator
$250,000

All 12 grants and awards

47 publications.

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.

Lemieux J, Côté I, Lemay M, Lauzier S, Després P, Desbiens C, Doyle C, Poirier B, Baghdadli A, Di Schiavi Trotta L, Nabi H

Current oncology (Toronto, Ont.)2026

DOI: 10.3390/curroncol33050272 PMID: 42187589

Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis.

Béchard L, Corbeil O, Huot-Lavoie M, Roy O, Brodeur S, Bouchard E, Martel J, Pavey N, Achim AM, Menear M, Roy MA, Lauzier S, Demers MF

BJPsych open2026

DOI: 10.1192/bjo.2026.11034 PMID: 42087272

Coronary Heart Disease Attributable to Psychosocial Stressors at Work.

Lavigne-Robichaud M, Trudel X, Talbot D, Milot A, Pena-Gralle APB, Mésidor M, Gilbert-Ouimet M, Niedhammer I, Sultan-Taïeb H, Dionne CE, Vézina M, Guénette L, Lauzier S, Maunsell E, Biron C, Pearce N, Mâsse B, Dagenais GR, Brisson C

JACC. Advances2025

DOI: 10.1016/j.jacadv.2025.102160 PMID: 40974958

Factors shaping the decision-making process to continue or discontinue antipsychotics: exploratory qualitative study of 12 individuals in remission from first-episode psychosis.

Béchard L, Anderson E, Corbeil O, Huot-Lavoie M, Brodeur S, Abdel-Baki A, Massé C, Gabriel-Courval M, Coté MÈ, LeBlanc A, Roy MA, Demers MF, Lauzier S

BJPsych open2025Senior author

DOI: 10.1192/bjo.2025.10817 PMID: 40904211

A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial.

Lapointe J, Guillaumie L, Dionne A, Lalonde L, Lemieux J, Dorval M, Nabi H, Lemay M, Guénette L, Guertin JR, Mâsse B, Lauzier S

Pilot and feasibility studies2025Senior author

DOI: 10.1186/s40814-025-01676-8 PMID: 40660375

Development of a Program to Optimize the Experience and the Use of At-Home Oral Chemotherapies in Pediatric Acute Lymphoblastic Leukemia: A Participatory Approach Using the Behavior Change Wheel.

Labbé A, Guillaumie L, D'Avignon MO, David PM, Lauzier S, Laverdière I

Journal of pediatric hematology/oncology nursing2025

DOI: 10.1177/27527530251337037 PMID: 40671587

Cross-cultural adaptation and validation of a French version of the perceived personal control questionnaire as an outcome measure instrument for genetic counseling.

Raîche C, Lapointe J, Villafane-Bernier C, Chiquette J, Bouchard K, Pelletier S, Omeranovic A, Fortier P, Brousseau C, Lauzier S, Hébert J, Dorval M, Nabi H

Journal of genetic counseling2025

DOI: 10.1002/jgc4.1989 PMID: 39462767

Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trial.

Souli I, Lapointe J, Kinsley-Marlie J, Chiquette J, Dorval M, Diorio C, Lauzier S, Audet-Walsh É, Bilodeau S, Côté M, Brisson C, Charette N, Fortier P, Paquette JS, Fradet Y, Savard J, Fradet V, Nabi H

BMJ open2025

DOI: 10.1136/bmjopen-2024-085255 PMID: 39961712

Exploring health related quality of life for women with breast cancer in Ireland and Québec, Canada throughout the COVID-19 pandemic.

Myers C, Bennett K, Cahir C, Savard J, Lauzier S

Scientific reports2025Senior author

DOI: 10.1038/s41598-024-84852-9 PMID: 39893230

Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study.

Turcotte V, Guillaumie L, Lemay M, Dionne A, Lemieux J, Labbé A, Gotay C, Guénette L, Lauzier S

Current oncology (Toronto, Ont.)2025Senior author

DOI: 10.3390/curroncol32010045 PMID: 39851961

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Adjuvant Endocrine Therapy Dear Professor Lauzier, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "PRIME-OncoTransition for Breast Cancer : A smooth hospital-community transition for people aged 65+ undergoing Post-tReatment preventIve MEdication." (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Sophie Lauzier

Research

Latest papers

Latest funding

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.

Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis.

Coronary Heart Disease Attributable to Psychosocial Stressors at Work.

Factors shaping the decision-making process to continue or discontinue antipsychotics: exploratory qualitative study of 12 individuals in remission from first-episode psychosis.

A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial.

Development of a Program to Optimize the Experience and the Use of At-Home Oral Chemotherapies in Pediatric Acute Lymphoblastic Leukemia: A Participatory Approach Using the Behavior Change Wheel.

Cross-cultural adaptation and validation of a French version of the perceived personal control questionnaire as an outcome measure instrument for genetic counseling.

Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trial.

Exploring health related quality of life for women with breast cancer in Ireland and Qu&#xe9;bec, Canada throughout the COVID-19 pandemic.

Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study.

Révolutionner la gestion de la douleur totale en soins palliatifs oncologiques : Une approche intégrative pharmacogénomique-spirituelle

Frequent collaborators

Laurence Guillaumie

Hermann Nabi

Xavier Trudel

Marie-France Demers

Denis Talbot

Chantal Brisson

Jean Bourbeau

Annie LeBlanc

Amal Abdel-Baki

Caroline Sirois

Vincent Fradet

Matthew Menear

Amal Abdel-Baki

Steve Bilodeau

Douglas Coyle

Jennifer Brunet

Louise Bordeleau

Caroline Diorio

Jalila Jbilou

Exploring health related quality of life for women with breast cancer in Ireland and Québec, Canada throughout the COVID-19 pandemic.